What are the major opportunities in the Prolastin-C market? What are the strategies for the Prolastin-C market?

For detailed insights on the major opportunities and strategies in the Prolastin-C market, Read More

How does the Prolastin-C market relate to the overall economy and other similar markets?

For detailed insights on Prolastin-C's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Prolastin-C industry?

For detailed insights on the mergers and acquisitions in the Prolastin-C industry, Read More

What are the key dynamics influencing the Prolastin-C market growth? SWOT analysis of the Prolastin-C market.

For detailed insights on the key dynamics influencing the Prolastin-C market growth and SWOT analysis of the Prolastin-C industry, Read More

Prolastin-C Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Prolastin-C Market Report 2026

Name: Prolastin-C Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type (20 ML, 40 ML), By Clinical Indication (Chronic Obstructive Pulmonary Disease (COPD), Liver Disease, Pulmonary Disease, Other Indications), By Application (Hospital, Pharmacy) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Prolastin-C Market Overview

• The Prolastin-C market growth in the historic period has been driven by approval for metastatic renal cell carcinoma, early success of immunotherapy approaches

• Market expansion is supported by growth of cancer immunotherapy research, renewed interest in cytokine therapies

• Growth Driver: Rising Respiratory Infections Drive Growth In The Prolastin-C Market

• Market Trend: Phase 3 Clinical Trial For Prolastin-C To Assess Efficacy In Slowing Emphysema Progression In AAT Deficiency Patients

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Prolastin-C Market?

Prolastin-C is a purified alpha-1 proteinase inhibitor (also known as alpha-1 antitrypsin or AAT) derived from human plasma. It is primarily used as an augmentation therapy for individuals with alpha-1 antitrypsin deficiency (AATD), a genetic condition that can lead to serious lung diseases such as emphysema. Prolastin-C works by increasing the levels of alpha-1 antitrypsin in the blood and lungs. This protein helps protect lung tissue from damage caused by neutrophil elastase, an enzyme that can degrade the elasticity of the lungs when unregulated.

The main types of prolastin C include 20 mL and 40 mL. Prolastin-C 20 mL is a sterile, ready-to-use liquid formulation of alpha-1 proteinase inhibitor, indicated for intravenous infusion in individuals with alpha-1 antitrypsin deficiency. It is used for various indications, including chronic obstructive pulmonary disease (COPD), liver disease, pulmonary disease, and others, and is applied in both hospitals and pharmacies.

Prolastin-C Market Global Report 2026 Market Report bar graph

What Is The Prolastin-C Market Size and Share 2026?

The growth in the historic period can be attributed to approval for metastatic renal cell carcinoma, early success of immunotherapy approaches, hospital oncology adoption, limited historic immunotherapy options, specialist administration protocols.

What Is The Prolastin-C Market Growth Forecast?

The growth in the forecast period can be attributed to growth of cancer immunotherapy research, renewed interest in cytokine therapies, combination treatment strategies, expansion of oncology centers, personalized cancer care focus. Major trends in the forecast period include continued use of cytokine based immunotherapy, application in advanced oncology care, hospital based il-2 administration, niche use in immuno oncology, combination with other cancer therapies.

Book your 30 minutes free consultation with our research experts

Global Prolastin-C Market Segmentation

1) By Type: 20 ML, 40 ML

2) By Clinical Indication: Chronic Obstructive Pulmonary Disease (COPD), Liver Disease, Pulmonary Disease, Other Indications

3) By Application: Hospital, Pharmacy

What Are The Drivers Of The Prolastin-C Market?

The increase in incidence of respiratory infections is expected to propel the growth of the prolastin-C market going forward. Respiratory infections refer to infections that affect the respiratory system, which includes the nose, throat, airways, and lungs. These infections are caused by various pathogens, such as viruses, bacteria, fungi, or other microorganisms. The rise in respiratory infections is driven by factors such as emerging viral strains, seasonal changes, and weakened immune systems, exacerbated by environmental pollution and increased human mobility. Prolastin-C, both forms of alpha-1 antitrypsin (AAT) replacement therapy, help manage respiratory diseases, particularly alpha-1 antitrypsin deficiency-related chronic obstructive pulmonary disease (COPD), by replenishing the deficient AAT protein, thereby reducing lung inflammation, protecting against tissue damage caused by protease activity, and improving lung function and overall respiratory health for patients affected by this genetic disorder. For instance, in October 2024, according to the National Asthma Council, an Australia-based non-profit organization, in 2023, Australia recorded a total of 474 asthma-related deaths, comprising 325 females and 149 males. This figure is almost identical to the 473 asthma-related deaths reported in 2022, highlighting a consistent trend in asthma mortality over the two years. Therefore, the increase in incidence of respiratory infections is driving the growth of the prolastin-C industry.

The increasing research and development expenditure is expected to propel the growth of the prolastin-C market going forward. Research and development (R&D) refers to the systematic and organized activities conducted by companies, organizations, or individuals to discover new knowledge, create innovative products, or improve existing processes and services. Research and development expenditure is rising due to increasing demand for innovation, technological advancements, and the need to develop new products and therapies in competitive markets. Increased research and development expenditure positively impacts prolastin-C by enabling advanced clinical trials, enhancing its efficacy, and accelerating the development of improved formulations or dosage regimens for better patient outcomes. For instance, in February 2025, according to the National Center for Science and Engineering Statistics (NCSES), a US-based government statistical agency, U.S. research and development expenditures rose from $892 billion in 2022 to $940 billion in 2023, reflecting an increase of $48 billion. Therefore, the increasing research and development expenditure is driving the growth of the prolastin-C industry.

Key Players In The Global Prolastin-C Market

Major companies operating in the prolastin-c market are Grifols S.A.

Global Prolastin-C Market Trends and Insights

Major companies operating in the prolastin-C market are focusing on clinical trials to assess the safety and effectiveness of pharmaceuticals. Clinical trials are research studies conducted to evaluate the safety, efficacy, and potential side effects of new treatments, drugs, or medical devices on human participants. For instance, in July 2023, Grifols SA, a Spain-based pharmaceutical company, announced that it had reached the target of enrolling 339 patients in the SPARTA (Study of ProlAstin-c Randomized Therapy with Alpha-1 Augmentation) phase 3 clinical trial. The purpose of this trial is to find out if patients with emphysema who have alpha-1-antitrypsin (AAT) deficiency (alpha-1) have a slower rate of lung tissue loss when they receive weekly treatment with two different dose regimens of Grifols Prolastin-C. This aims to assess the effectiveness of Prolastin-C in reducing emphysema progression in alpha-1 antitrypsin deficiency (AATD) patients by increasing AAT protein levels through weekly administration of two active doses (60 and 120 mg/kg) compared to a placebo.

Need data on a specific region in this market?

Request Regional Data

Regional Insights

North America was the largest region in the prolastin-C market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Prolastin-C Market?

The prolastin-C market consists of sales of inhalable pulmonary medications, nutritional supplements and other related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Prolastin-C Market Report 2026?

The prolastin-c market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the prolastin-c industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Prolastin-C Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$ billion
Revenue Forecast In 2035	$ billion
Growth Rate	No CAGR found from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type, Clinical Indication, Application
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Grifols S.A.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Prolastin-C Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Prolastin-C Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Prolastin-C Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Prolastin-C Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Continued Use Of Cytokine Based Immunotherapy

4.2.2 Application In Advanced Oncology Care

4.2.3 Hospital Based Il-2 Administration

4.2.4 Niche Use In Immuno Oncology

4.2.5 Combination With Other Cancer Therapies

5. Prolastin-C Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Oncology Centers

5.3 Cancer Treatment Institutes

5.4 Academic Medical Centers

5.5 Specialty Clinics

6. Prolastin-C Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Prolastin-C Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Prolastin-C PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Prolastin-C Market Size, Comparisons And Growth Rate Analysis

7.3. Global Prolastin-C Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Prolastin-C Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Prolastin-C Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Prolastin-C Market Segmentation

9.1. Global Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20 ML, 40 ML

9.2. Global Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chronic Obstructive Pulmonary Disease (COPD), Liver Disease, Pulmonary Disease, Other Indications

9.3. Global Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital, Pharmacy

10. Prolastin-C Market Regional And Country Analysis

10.1. Global Prolastin-C Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Prolastin-C Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Prolastin-C Market

11.1. Asia-Pacific Prolastin-C Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Prolastin-C Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Prolastin-C Market

12.1. China Prolastin-C Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Prolastin-C Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Prolastin-C Market

13.1. India Prolastin-C Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Prolastin-C Market

14.1. Japan Prolastin-C Market Overview

14.2. Japan Prolastin-C Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Prolastin-C Market

15.1. Australia Prolastin-C Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Prolastin-C Market

16.1. South Korea Prolastin-C Market Overview

16.2. South Korea Prolastin-C Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Prolastin-C Market

17.1. Western Europe Prolastin-C Market Overview

17.2. Western Europe Prolastin-C Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Prolastin-C Market

18.1. UK Prolastin-C Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Prolastin-C Market

19.1. Germany Prolastin-C Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Prolastin-C Market

20.1. France Prolastin-C Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Prolastin-C Market

21.1. Eastern Europe Prolastin-C Market Overview

21.2. Eastern Europe Prolastin-C Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Prolastin-C Market

22.1. North America Prolastin-C Market Overview

22.2. North America Prolastin-C Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Prolastin-C Market

23.1. USA Prolastin-C Market Overview

23.2. USA Prolastin-C Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Prolastin-C Market

24.1. Canada Prolastin-C Market Overview

24.2. Canada Prolastin-C Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Prolastin-C Market

25.1. South America Prolastin-C Market Overview

25.2. South America Prolastin-C Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Prolastin-C Market

26.1. Middle East Prolastin-C Market Overview

26.2. Middle East Prolastin-C Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Prolastin-C Market

27.1. Africa Prolastin-C Market Overview

27.2. Africa Prolastin-C Market, Segmentation By Type, Segmentation By Clinical Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Prolastin-C Market Regulatory and Investment Landscape

29. Prolastin-C Market Competitive Landscape And Company Profiles

29.1. Prolastin-C Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Prolastin-C Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Prolastin-C Market Company Profiles

29.3.1. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis

30. Global Prolastin-C Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Prolastin-C Market

32. Prolastin-C Market High Potential Countries, Segments and Strategies

32.1 Prolastin-C Market In 2030 - Countries Offering Most New Opportunities

32.2 Prolastin-C Market In 2030 - Segments Offering Most New Opportunities

32.3 Prolastin-C Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Prolastin-C Market, Overview Of Key Products - Product Examples

Table 2: Global Prolastin-C Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Prolastin-C Market, Supply Chain Analysis

Table 4: Global Prolastin-C Market, Major Raw Material Providers

Table 5: Global Prolastin-C Market, Major Resource Providers

Table 6: Global Prolastin-C Market, Major Manufacturers (Suppliers)

Table 7: Global Prolastin-C Market, Major Distributors And Channel Partners

Table 8: Global Prolastin-C Market, Key Technologies & Future Trends

Table 9: Global Prolastin-C Market, Major Trends

Table 10: Global Prolastin-C Market, Major End Users

Table 11: Global Prolastin-C Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Prolastin-C Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Prolastin-C Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Prolastin-C Market - TAM, US$ Billion, 2025

Table 15: Global Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Prolastin-C Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Prolastin-C Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Asia-Pacific, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Asia-Pacific, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: China, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: China, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: India, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: India, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Japan, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: Japan, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Australia, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Australia, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: South Korea, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: South Korea, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: South Korea, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Western Europe, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Western Europe, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Western Europe, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: UK, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: UK, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: UK, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Germany, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Germany, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Germany, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: France, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: France, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: France, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Eastern Europe, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Eastern Europe, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Eastern Europe, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: North America, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: North America, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: North America, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: USA, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: USA, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: USA, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Canada, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Canada, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Canada, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: South America, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: South America, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: South America, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Middle East, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Middle East, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Middle East, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Africa, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Africa, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Africa, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Global Prolastin-C Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 72: Global Prolastin-C Market - Company Scoring Matrix

Table 73: Grifols S.A. Financial Performance

Table 74: Global Prolastin-C Market, Competitive Benchmarking (In USD Billions)

Table 75: Global Prolastin-C Market, Competitive Dashboard

Table 76: Global Prolastin-C Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 77: Global, Prolastin-C Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Table 78: Global, Prolastin-C Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030

Table 79: Global, Prolastin-C Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Prolastin-C Market, Overview Of Key Products - Product Examples

Figure 2: Global Prolastin-C Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Prolastin-C Market, Supply Chain Analysis

Figure 4: Global Prolastin-C Market, Major Raw Material Providers

Figure 5: Global Prolastin-C Market, Major Resource Providers

Figure 6: Global Prolastin-C Market, Major Manufacturers (Suppliers)

Figure 7: Global Prolastin-C Market, Major Distributors And Channel Partners

Figure 8: Global Prolastin-C Market, Key Technologies & Future Trends

Figure 9: Global Prolastin-C Market, Major Trends

Figure 10: Global Prolastin-C Market, Major End Users

Figure 11: Global Prolastin-C Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Prolastin-C Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Prolastin-C Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Prolastin-C Market - TAM, US$ Billion, 2025

Figure 15: Global Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Prolastin-C Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Prolastin-C Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Asia-Pacific, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Asia-Pacific, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: China, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: China, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: India, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: India, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Japan, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: Japan, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Australia, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Australia, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: South Korea, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: South Korea, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: South Korea, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Western Europe, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Western Europe, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Western Europe, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: UK, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: UK, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: UK, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Germany, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Germany, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Germany, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: France, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: France, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: France, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Eastern Europe, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Eastern Europe, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Eastern Europe, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: North America, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: North America, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: North America, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: USA, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: USA, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: USA, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Canada, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Canada, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Canada, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: South America, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: South America, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: South America, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Middle East, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Middle East, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Middle East, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Africa, Prolastin-C Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Africa, Prolastin-C Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Africa, Prolastin-C Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Global Prolastin-C Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 72: Global Prolastin-C Market - Company Scoring Matrix

Figure 73: Grifols S.A. Financial Performance

Figure 74: Global Prolastin-C Market, Competitive Benchmarking (In USD Billions)

Figure 75: Global Prolastin-C Market, Competitive Dashboard

Figure 76: Global Prolastin-C Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 77: Global, Prolastin-C Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030

Figure 78: Global, Prolastin-C Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030

Figure 79: Global, Prolastin-C Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Competitive and Market Trend Analysis of Gastric Cancer Therapy Industry Through 2029

Industry Trends Show Gastrointestinal Therapeutics Market Set to Expand at 5.5% CAGR Until 2029

Key Market Drivers, Trends, and Forecast for the Global Gene-Editing Transfection Chemicals Industry

Outlook for Generic Pharmaceuticals Contract Manufacturing Market: Key Developments and Future Strategies to 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Alpha Mannosidosis Market Report 2026 - Global Outlook – By Therapy Type (Bone Marrow Transplant (BMT), Enzyme Replacement Therapy (ERT), Other Therapies), By Indication (Type I, Type II, Type III), By End-User (Hospital...

TNF Alpha Inhibitors Market Report 2026 - Global Outlook – By Drug (Remicade (Infliximab), Enbrel (Etanercept), Humira (Adalimumab), Cimzia (Certolizumab Pegol), Simponi (Golimumab) ), By Route Of Administration (Subcuta...

Alpha Methyldopa Market Report 2026 - Global Outlook – By Type (Oral, Intravenous Drip), By Purity Type (Purity: =98%, Purity:=99%), By Application (Parkinsonism, Hepatic Coma) - Market Size, Trends, And Global Forecast ...

Kidney Cancer Drugs Market Report 2026 - Global Outlook – By Cancer Type (Renal Cell Carcinoma (RCC), Transitional Cell Carcinoma (TCC) Or Urothelial Cell Carcinoma (UCC)), By Product (Nexavar (Sorafenib), Sutent (Suniti...

Ovarian Cancer Drugs Market Report 2026 - Global Outlook – By Tumor Type (Epithelial Ovarian Cancer, Germ Cell Ovarian Cancer, Stromal Cell Ovarian Cancer), By Drug Type (Alkylating Agents, Mitotic Inhibitors, VEGF/VEGFR...

Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Report 2026 - Global Outlook – By Treatment Type (Symptomatic Drug Therapy, Supportive Care Therapy, Palliative Care), By Symptom Management (Seizure Management,...

5-Alpha Reductase Deficiency Market Report 2026 - Global Outlook – By Diagnosis (Chromosome Analysis, Gene Sequencing, Hormone Tests, Imaging Tests, Genetic Screening, Other Diagnosis), By Treatment (Surgery, Vaginoplast...

Frequently Asked Questions

How big is the Prolastin-C Market?

The Prolastin-C market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030. request a sample here

What is the Prolastin-C market growth?

The global Prolastin-C market is expected to grow at a CAGR of nan% from 2026 to 2035 to reach $ billion by 2035. request a sample here

Who are the key players in Prolastin-C market?

Some Key Players in the Prolastin-C market Include, Grifols S.A. . request a sample here

What is the anticipated growth trend for the Prolastin-C market?

Major trend in this market includes: Phase 3 Clinical Trial For Prolastin-C To Assess Efficacy In Slowing Emphysema Progression In AAT Deficiency Patients. For further insights on this market. request a sample here

Which region has the most growth potential in the Prolastin-C market?

North America was the largest region in the prolastin-C market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prolastin-c market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Prolastin-C Market Report 2026 market?

Major companies operating in the Prolastin-C Market Report 2026 market are Major companies operating in the prolastin-c market are Grifols S.A. request a sample here.

Which region has the most growth potential in the Prolastin-C Market Report 2026 market?